Antimicrobial activity of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples